1. Opening Hook

While most SMEs spend concalls apologising for margins, Prevest DenPro showed up flexing a 39% EBITDA margin like it’s normal behaviour.
Exports are back, the U.S. tariffs are “temporary,” digital dentistry is the future (again), and capacity utilisation is proudly… below 5%.

Yes, you read that right.
A company running at luxury-car margins, building printers for dentists, selling disinfectants, and still saying “we don’t want low-margin business.”

Domestic growth stumbled, blamed on floods, GST, and a near-war situation—because apparently dental demand also needs geopolitical peace.
But Q2 bounced back hard, management sounded relaxed, and the word “₹100 crore” was dropped without dramatic background music.

Read on. The confidence is either earned—or dangerously comfortable.

2. At a Glance

• Revenue ₹34.4 cr (H1) – Quietly up 16%, no chest-thumping required.
• EBITDA ₹14.35 cr – 39% margin, dentists apparently pay on time.
• PAT ₹9.95 cr – 27% margin, SMEs taking notes nervously.
• Exports up 24% YoY – Currency pain healed, orders back.
• Q2 QoQ growth ~19% – Floods left the building.

3. Management’s Key Commentary

“Export revenues have grown by 24% year-on-year.”
(Translation: Currency drama ended, cheques resumed.) 😏

“Digital dentistry will become an important pillar.”
(Translation: Hardware + resin = sticky customers.)

“We are not even utilising 5% of resin capacity.”
(Translation: Capex already done, growth doesn’t need permission.)

“The U.S. is the world’s largest dental market.”
(Translation: We’ll tolerate tariffs for that prize.)

“Oradox will become a strong recurring revenue stream.”
(Translation: FMCG patience required.)

“We do not want low-margin products.”
(Translation: Volume merchants please exit.) 😬

4. Numbers Decoded

This is not a company chasing scale blindly—it’s chasing margin-led scale.

5. Analyst Questions (Decoded)

• Why domestic growth slowed?
  Floods, GST reset, Jammu disruptions.
  (Translation: One bad quarter, not a trend.)